Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 584-592

  Coughenour, Linda L ^a   Cordon, John J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELIPRODIL; HALOPERIDOL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SPERMIDINE; TENOCYCLIDINE; TRIFLUPERIDOL; TRITIUM; VANOXERINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BINDING SITE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; FOREBRAIN; ISOTOPE LABELING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CELL MEMBRANE; FEMALE; HALOPERIDOL; KINETICS; OOCYTES; PHENCYCLIDINE; PIPERIDINES; RADIOLIGAND ASSAY; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; RECOMBINANT PROTEINS; STREET DRUGS; TRIFLUPERIDOL; XENOPUS;

EID: 0030985614     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 3H]GBR 12935 binding in vitro to rat striatal membranes: Labeling of the dopamine uptake complex. J. Neurochem. 48: 1887-1896, 1987.
2. 125I]ifenprodil in washed, frozen-thawed synaptic membranes: Evidence for high-affinity binding requiring an open NMDA channel. Neurosci. Lett. 142: 219-222, 1992.
3. BULLER, A. L., LARSON, H. C., SCHNEIDER, B. E., BEATON, J. A., MORRISETT, R. A. AND MONAGHAN, D. T.: The molecular basis of NMDA receptor subtypes: Native receptor diversity is predicted by subunit composition. J. Neurosci. 14: 5471-5484, 1994.
4. CARTER, C. J., LLOYD, K. G., ZIVKOVIC, B. AND SCATTON, B.: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. J. Pharmacol. Exp. Ther. 253: 475-482, 1990.
5. COLLINGRIDGE, G. L. AND LESTER, R. A. J.: Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 40: 143-210, 1989.
6. 3H](+)-3-PPP to σ binding sites in rat brain. Neurosci. Lett. 116: 190-193, 1990a.
7. 3H](+)3-PPP to sigma receptors in rat brain (Abstract). Life Sci. 47: PL-133-PL-137, 1990b.
8. 3H]ifenprodil binding sites in the rat brain. Neurosci. Lett. 125: 45-48, 1991.
9. FLETCHER, E. J. AND MACDONALD, J. F.: Haloperidol interacts with the strychnine-insensitive glycine site at the NMDA receptor in cultured mouse hippocampal neurones. Eur. J. Pharmacol. 235: 291-295, 1993.
10. 3H]ifenprodil binding in rat brain. Eur. J. Pharmacol. 266: 67-77, 1994.
11. HOLLMANN, M. AND HEINEMANN, S.: Cloned glutamate receptors. Ann. Rev. Neurosci. 17: 31-108, 1994.
12. ILYIN, V., WHITTEMORE, E. R. AND WOODWARD, R. M.: Antagonism of NMDA receptors by sigma site ligands. Soc. Neurosci. Abstracts 21: 835, 1995.
13. ILYIN, V. I., WHITTEMORE, E. R., GUASTELLA, J., WEBER, E. AND WOODWARD, R. M.: Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol. Pharmacol. 50: 1541-1550, 1996.
14. JONES, S. M., SNELL, L. D. AND JOHNSON, K. M.: Characterization of the binding of radioligands to the N-methyl-D-aspartate, phencyclidine, and glycine receptors in buffy coat membranes. J. Pharmacol. Meth. 21: 161-168, 1989.
15. 3H](+)-3PPP-labeled σ binding sites in guinea pig brain membranes. Eur. J. Pharmacol. 176: 247-248, 1990.
16. LAURIE, D. J. AND SEEBURG, P. H.: Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268: 335-345, 1994.
17. LYNCH, D. R., LAWRENCE, J. J., LENZ, S., ANEGAWA, N. J., DICHTER, M. AND PRITCHETT, D. B.: Pharmacological characterization of heterodimeric NMDA receptors composed of NR 1a and 2B subunits: Differences with receptors formed from NR 1a and 2A. J. Neurochem. 64: 1462-1468, 1995.
18. 125I-lfenprodil: Synthesis and characterization of binding to a polyamine-sensitive site in cerebral cortical membranes. J. Neurochem. 61: 120-126, 1993.
19. 3H]-ifenprodil sites in the rat brain: Possible relationship to NMDAR2B receptors and calmodulin. J. Neurochem. 63: 2248-2258, 1994.
20. OLNEY, J. W.: Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol. 30: 47-71, 1990.
21. PORTERA-CAILLIAU, C., PRICE, D. L. AND MARTIN, L. J.: N-Methyl-D-aspartate receptor proteins NR2A and NR2B are differentially distributed in the developing rat central nervous system as revealed by subunit-specific antibodies. J. Neurochem. 66: 692-700, 1996.
22. REYNOLDS, I. J. AND MILLER, R. J.: Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: Interaction with polyamines. Mol. Pharmcol. 36: 758-765, 1989.
23. REYNOLDS, I. J. AND MILLER, R. J.: Allosteric modulation of N-methyl-D-aspartate receptors. Adv. Pharmacol. 21: 101-126, 1990.
24. ROCK, D. M. AND MACDONALD, R. L.: Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu. Rev. Pharmacol. Toxicol. 35: 463-482, 1995.
25. ROMANO, C. AND WILLIAMS, K.: Modulation of NMDA receptors by polyamines. In The Neuropharmacology of Polyamines, ed. by C. Carter, pp. 81-106 Academic Press, San Diego, 1994.
26. SCATTON, B., AVENET, P., BENAVIDES, J., CARTER, C., DUVERGER, D., OBLIN, A. PERRAULT, G., SANGER, D. J. AND SCHOEMAKER, H.: Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists ifenprodil and eliprodil. In Direct and Allosteric Control of Glutamate Receptors, ed. by M. G. Palfreyman, I. J. Reynolds and P. Skolnick, pp. 139-154, CRC Press, 1994.
27. 3H]ifenprodil binding to the rat cerebral cortex. Br. J. Pharmacol. 100: 316P, 1990.
28. SCHOEMAKER, H., PIGASSE, S., CABOI, F, AND OBLIN, A.: Polyamine effects on radioligand binding to receptors and recognition sites. In The Neuropharmacology of Polyamines, ed. by C. Carter, pp. 107-154, Academic Press, 1995.
29. WILLIAMS, K.: Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors. Mol. Pharmacol. 44: 851-859, 1993.
30. WILLIAMS, K.: Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Mol. Pharmacol. 46: 161-168, 1994.
31. WILLIAMS, K., RUSSELL, S. L., SHEN, Y. M. AND MOLINOFF, P. B.: Developmental switch in the expression of the NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278, 1993.
32. WILLIAMS, K., ZAPPIA, A. M., PRITCHETT, D. B., SHEN, Y. M. AND MOLINOPF, P. B.: Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol. 45: 803-809, 1994.
33. WONG, E. H. F. AND KEMP, J. A.: Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu. Rev. Pharmacol. Toxicol. 31: 401-425, 1991.
34. YONEDA, Y. AND OGITA, K: Neurochemical aspects of the N-methyl-D-aspartate receptor complex. Neurosci. Res. 10: 1-33, 1991.
35. ZHANG, L., ZHENG, X., PAUPARD, M.-C., WANG, A. P., SANTCHI, L., FRIEDMAN, L. K., ZUKIN, R. S. AND BENNETT, M. V. L.: Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition. Proc. Natl. Acad. Sci. U.S.A. 91: 10883-10887, 1994.
36. ZUKIN, R. S. AND BENNETT, M. V. L.: Alternatively spliced isoforms of the NMDAR1 receptor subunit. Trends Neurosci. 18: 306-313, 1995.